Work from the Stand Up To Cancer Convergence 3.1416 Research Team led by Dan Littman NYU Langone Health and a Stand Up To Cancer Sharp Award was published in nature describing how dendritic cells are able to regulate T cell responses to food and microbes and contribute to food tolerance nature.com/articles/s4158…

Noninvasive mutation and fragmentation-based cfDNA approaches are able to identify therapeutic response of individuals with pancreatic cancer according to a paper in Science Advances by Victor Velculescu Johns Hopkins Medicine of the Stand Up To Cancer-KWFKankerbestrijding and Stand Up To Cancer-American Lung Association-LUNGevity Foundation

Noninvasive mutation and fragmentation-based cfDNA approaches are able to identify therapeutic response of individuals with pancreatic cancer according to a paper in Science Advances by Victor Velculescu Johns Hopkins Medicine of the Stand Up To Cancer-KWFKankerbestrijding and Stand Up To Cancer-American Lung Association-LUNGevity Foundation

Noninvasive mutation and fragmentation-based cfDNA approaches are able to identify therapeutic response of individuals with pancreatic cancer according to a paper in Science Advances by Victor Velculescu Johns Hopkins Medicine of the Stand Up To Cancer-KWFKankerbestrijding and Stand Up To Cancer-American Lung Association-LUNGevity Foundation

A new method reveals unexpected behavior in molecular crowding during cell state transitions suggesting density as a biomarker for functional precision medicine according to a paper in Nature Biomedical Engineering from Stand Up To Cancer Convergence 3.1416 Research Team member Scott Manalis Massachusetts Institute of Technology (MIT)

Research by the Van Andel Institute (VAI)-Stand Up To Cancer Epigenetics Dream Team defines the ASCL1-FOXA2 axis as a critical driver of multiorgan SCLC metastasis according to a paper just published in Nature Communications nature.com/articles/s4146…

Check out the upcoming NYAS Frontiers in Cancer Immunology Symposium. The event features a number of current and former Stand Up To Cancer – funded researchers, including Benjamin D. Greenbaum, @JimAllisonPhD, Antoni Ribas, Taha Merghoub, and Padmanee Sharma. #immunology #cancer

Toni Ribas from UCLA Health kicks off the NYAS #cancerimmunotherapy conference at Weill Cornell Medicine describing the basic rules for PD-1 response to immunotherapy.

Wonderful talk at NYAS #cancerimmunotherapy conference by Anca Apavaloaei from Weill Cornell Medicine describing novel targets for #gastroesophageal cancer, including LINE-1.

Taha Merghoub from Weill Cornell Medicine describes the role of innate immunity in the tumor microenvironment at the NYAS #cancerimmunology symposium.

The Stand Up To Cancer Multiple Myeloma Dream Team published in Nature Genetics describing their MM precursor genomic map in order to better inform risk assessment and monitoring of MM precursor conditions. nature.com/articles/s4158…

J. Silvio Gutkind UC San Diego, a member of the Stand Up To Cancer-Fanconi Cancer Foundation- Farrah Fawcett Fnd. Head & Neck Research Team, presented a talk entitled "Repurposing metformin for oral cancer precision prevention: Halting the malignant reprogramming of epithelial stem cells" at the

New Request for Applications! The Stand Up To Cancer Lung Cancer Early Detection Challenge is now open! For more information, please click the link below or search Stand Up To Cancer in Proposal Central under Grant Opportunities. #LungCancer #EarlyDetection #StandUpToCancer

A project initiated by the Stand Up To Cancer Breast Cancer Dream Team was published in npj Journals Precision Oncology utilizing cohort-level and individual networks to predict best response in patients with metastatic triple negative breast cancer nature.com/articles/s4169…

The GBM chatbot is going live on the Stand Up To Cancer website on 7/16. This AI companion was developed by Jason Binder after his wife was diagnosed with glioblastoma to help patients and family members to understand glioblastoma, explore options, and feel less alone on this journey. #GBMDay

According to a paper published in Cancer Cell by the Stand Up To Cancer Colorectal Cancer Dream, they have been able to use mutagenic agents to engineer an MMRd genotype in immunoresistant cells to generate an immunogenic phenotype cell.com/cancer-cell/ab…

Request for Applications! The Stand Up To Cancer - Cancer Research UK Prevention, Early Stage Detection, and Interception of Recurrence Challenge is now open! For more information, please click the link below or search Stand Up To Cancer in Proposal Central under Grant Opportunities. #EarlyDetection

A study in Nature Communications uses #ML and a multi-institutional clinicogenomic dataset generated by the Stand Up To Cancer-American Cancer Society Lung Cancer Dream Team to improve immune checkpoint monotherapy or combination #immunotherapy-#chemotherapy for patients with #NSCLC. nature.com/articles/s4146…

The Stand Up To Cancer Catalyst®-Genentech Team led by Matthew Block and Tina J Hieken MD just published the results of Arm C of the NeoACTIVATE trial in the European Journal of Cancer showing that among patients with high-risk resectable Stage III melanoma, neoadjuvant atezolizumab/tiragolumab is a